Thalidomide can effectively prevent relapse in IgG4-related disease outweighing its side effects: a multicentre, randomised, double-blinded, placebo-controlled study
Thalidomide can effectively prevent relapse in IgG4-RD outweighing its side effects, which indicating that thalidomide can be a potential safe therapeutic option for disease relapse prevention in parallel with steroid sparing in IgG4-RD.
Authors
- Pingting Yang (ORCID: https://orcid.org/0000-0002-2800-7947)
- Lie Dai (ORCID: https://orcid.org/0000-0001-6596-8889)
- Jungong Zhao (ORCID: https://orcid.org/0000-0001-5823-2179)
- Hisanori Umehara (ORCID: https://orcid.org/0000-0001-9833-4647)
- Shaozhe Cai (ORCID: https://orcid.org/0000-0001-6778-9745)
- Rui Wu (ORCID: https://orcid.org/0000-0002-7235-8955)
- Shuang Ding (ORCID: https://orcid.org/0000-0002-2181-9918)
- Le‐Feng Chen (ORCID: https://orcid.org/0000-0002-2902-3922)
- Lingli Dong (ORCID: https://orcid.org/0000-0003-2017-1125)
- Chuangxin Liao (ORCID: https://orcid.org/0000-0002-5264-9739)
- Wei Wei (ORCID: https://orcid.org/0009-0009-2433-413X)
- Cong Ye (ORCID: https://orcid.org/0000-0001-5478-7361)
- Wen Zhang (ORCID: https://orcid.org/0000-0001-7808-9867)
- Yu Chen (ORCID: https://orcid.org/0000-0002-7142-8851)
- Wei Sun
- Xiuhua Wu
Institutions
- Union Hospital (HK)
- Nanchang University (CN)
- Sun Yat-sen University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Tianjin Medical University General Hospital (CN)
- Sun Yat-sen Memorial Hospital (CN)
- First Hospital of China Medical University (CN)
- Nagahama City Hospital (JP)
- Tongji Hospital (CN)
- First Affiliated Hospital of Nanchang University (CN)
- Huazhong University of Science and Technology (CN)
- China Medical University (CN)
Publication Details
- Journal
- Annals of the Rheumatic Diseases
- Published
- 2025-02-15
- DOI
- https://doi.org/10.1016/j.ard.2025.01.033
- Citations
- 10
- Primary Topic
- IgG4-Related and Inflammatory Diseases
- Type
- article
- Field-Weighted Citation Impact
- 16.68
Funders
- National Natural Science Foundation of China
- Huazhong University of Science and Technology
- Tongji University
- Tongji Hospital